Medical - - May 10,2017
A recent informative report on Market Research Reports Search Engine (MRRSE) predicts the global E. coli testing market will rise at a CAGR of 8.0% between 2017 and 2025.
E. coli (Escherichia coli) is a fecal coliform bacteria usually found in humans and animals intestines. Most of these E. coli bacteria are innocuous, however certain varieties of E. coli can cause harmful medical complications.
These complications can be in the form of gastrointestinal infections, neonatal meningitis, bacteremia, cholecystitis, cholangitis, urinary tract infection (UTI) and pneumonia. It can also spread via contaminated water or food.
Sudden emergence of drug resistant E. coli strains has raised serious health issues. The epidemic has spread to several parts of the world including the United States and Europe. This has created pressure on governments and regulatory agencies to adopt protective measures to prevent such epidemics.
Environment Protection Agencies (EPA) have laid down strict guidelines for water and food testing. These guidelines are to be followed by bottled water suppliers, municipal water suppliers, private well owners and waste water treatment plants. Spurred by these factors, the market for E. Coli Testing is expected to reach US$2.36 billion by 2025 from US$1.18 billion in 2016.
The biggest end-user of this market is the home and drinking water segment, which holds over 49.7% of the market. While this segment is likely to remain at the top in the near future, the market will also experience a growing demand from waste water treatment organizations.
Some of the key companies operating in the global E. coli testing market include Meridian Bioscience Inc., IDEXX Laboratories, Inc., Dickinson and Company, Thermo Fisher Scientific Inc., Pro-Lab Diagnostics Inc., Becton, CPI International Inc., Bio-Rad Laboratories Inc., Alere Inc., BioMerieux Inc., and NanoLogix Inc.
For more information on this report visit - http://www.mrrse.com/e-coli-testing-market